Cover Image
市場調查報告書

Vichem Chemie Research Ltd.:產品平台分析

Vichem Chemie Research Ltd - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 293923
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Vichem Chemie Research Ltd.:產品平台分析 Vichem Chemie Research Ltd - Product Pipeline Review - 2016
出版日期: 2016年12月30日 內容資訊: 英文 32 Pages
簡介

Vichem Chemie Research Ltd. 是致力於使用激酶抑制劑的信號傳達療法的研究開發的生物科技研究型企業。提供激化酵素抑制劑庫,體外生物學,ADMET的最佳化,藥物發明標的蛋白質的提高等,各種服務。

這份報告提供Vichem Chemie Research Ltd.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、後期階段及中止的計劃相關資訊等。

Vichem Chemie Research Ltd.的基本資料

  • Vichem Chemie Research Ltd.概要
  • 主要資訊
  • 企業資料

Vichem Chemie Research Ltd.:R&D概要

  • 主要的治療範圍

Vichem Chemie Research Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Vichem Chemie Research Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Vichem Chemie Research Ltd.:藥物簡介

  • 中樞神經系統、自體免疫疾病小分子
  • HIV-第一型感染疾病 CDK9 抑制小分子
  • VID-45110
  • BBH-7
  • BTP-15
  • 未公佈的症狀的 VEGFR2 拮抗小分子
  • 非小細胞肺癌、肺腺癌的 EGFR 阻礙細分
  • 急性骨髓白血病的 FLT3 抑制小分子
  • 癌症、細菌感染疾病 的PLK1 抑制小分子
  • 未公佈的症狀的 ROCK2 抑制小分子
  • 慢性心臟疾病的小分子
  • 大腸菌感染疾病的小分子
  • 多發性骨髓瘤的小分子
  • 腫瘤學的 HGFR/EGFR 拮抗小分子
  • 腫瘤學的 Pan FGFR 拮抗小分子
  • 腫瘤學的 PDGFR-beta 拮抗小分子
  • 腫瘤學的Aurora-A激酶 抑制小分子
  • 腫瘤學的Aurora-B激酶 抑制小分子
  • 腫瘤學的抑制小分子 CDK4
  • VCC-405567
  • VCC-668662

Vichem Chemie Research Ltd.:開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Vichem Chemie Research Ltd.:暫停中的計劃

Vichem Chemie Research Ltd.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08198CDB

Summary

Global Markets Direct's, 'Vichem Chemie Research Ltd - Product Pipeline Review - 2016', provides an overview of the Vichem Chemie Research Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Vichem Chemie Research Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Vichem Chemie Research Ltd
  • The report provides overview of Vichem Chemie Research Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Vichem Chemie Research Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Vichem Chemie Research Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Vichem Chemie Research Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Vichem Chemie Research Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Vichem Chemie Research Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vichem Chemie Research Ltd Snapshot
    • Vichem Chemie Research Ltd Overview
    • Key Facts
  • Vichem Chemie Research Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Vichem Chemie Research Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Pipeline Products Glance
    • Vichem Chemie Research Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Drug Profiles
    • BBH-7 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • BTP-15 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Tuberculosis - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Melanoma - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK9 for HIV-1 Infection - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit IRS-1 for Type 2 Diabetes - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit Pan FGFR for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • VCC-234718 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Vichem Chemie Research Ltd - Pipeline Analysis
    • Vichem Chemie Research Ltd - Pipeline Products by Target
    • Vichem Chemie Research Ltd - Pipeline Products by Molecule Type
    • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action
  • Vichem Chemie Research Ltd - Dormant Projects
  • Vichem Chemie Research Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vichem Chemie Research Ltd, Key Facts
  • Vichem Chemie Research Ltd - Pipeline by Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Vichem Chemie Research Ltd - Preclinical, 2016
  • Vichem Chemie Research Ltd - Discovery, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
  • Vichem Chemie Research Ltd - Dormant Developmental Projects,2016

List of Figures

  • Vichem Chemie Research Ltd - Pipeline by Top 10 Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top